Conferences - Results from #9380

ESMO 2017: Second-line treatment patterns and outcomes of metastatic bladder cancer patients in clinical practice September 13, 2017

ESMO 2017: Outcomes of patients with metastatic urothelial carcinoma with exclusive bone metastases: Focus on a special patient population September 13, 2017

WCE 2017: Automated and dynamic classification of bladder cancer using deep learning on real-time confocal laser endomicroscopy images September 13, 2017

ESMO 2017: Identification of genomic features underlying response of muscle-invasive bladder cancer to neoadjuvant sorafenib, gemcitabine, and cisplatin in an open-label, single-arm, phase 2 study September 13, 2017

WCE 2017: Kidney irreversible electroporation does not cause significant injury to adjacent ureter or bowel in a porcine model September 13, 2017

WCE 2017: Experimental Study for a New Medical Adhesion-Prevention Agent after Laparoscopic Nephrectomy September 13, 2017

WCE 2017: Should All UTUC Patients be Screened for Lynch Syndrome? A Single Center Analysis of the Role of Screening UTUC patients for Lynch Syndrome September 13, 2017

ESMO 2017: Kidney Cancer Poster Discussion – Invited Discussant September 13, 2017

WCE 2017: Use of the Selective Cholesterol Absorption Inhibitor, Ezetimibe, and Subsequent Risk for Urolithiasis September 13, 2017

WCE 2017: Single Surgeon Experience with Revision of Ureteroenteric Anastomosis for Benign Strictures after Urinary Diversion September 13, 2017

WCE 2017: Arbutin as a novel prevention and therapy for calcium oxalate nephrolithiasis September 13, 2017

WCE 2017: Effect of Testosterone Impregnated Pellet Therapy on Lower Urinary Tract Symptoms September 13, 2017

WCE 2017: Role of Chaperone Proteins in Obstructed Renal Pelvis September 13, 2017

ESMO 2017: Adjuvant chemotherapy after radical nephroureterectomy does not improve survival in patients with upper tract urothelial carcinoma: A joint study of the EAU-Young Academic Urologists and the Upper Tract Urothelial Carcinoma Collaboration September 13, 2017

ESMO 2017: Avelumab treatment of metastatic urothelial carcinoma in the phase 1b JAVELIN Solid Tumor study: Updated analysis with ≥6 months of follow-up in all patients September 13, 2017

ESMO 2017: Immunotherapy for Urothelial Cancer – Longer Follow-up and Subgroup Analyses: Invited Discussant September 13, 2017

ESMO 2017: 14 years of progress in mCRPC – New avenues for immunotherapy and precision medicine: Invited Discussant September 13, 2017

ESMO 2017: Prostate Cancer Poster Discussion: Invited Discussant September 13, 2017

ESMO 2017: Urothelial Carcinoma Poster Discussion – Invited Discussant September 13, 2017

ESMO 2017: Biological assessment of viable germ cell tumor in patients with seminoma and non-seminoma using miR371 September 13, 2017

Page 470 of 616